Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233

European Journal of Radiology Open

Volumn 2, Issue , 2015, Pages 11-18

  Atri, Mostafa ^a   Zhang, Zheng ^b   Marques, Helga ^b   Gorelick, Jeremy ^b   Harisinghani, Mukesh ^c   Sohaib, Aslam ^d   Koh, Dow Mu ^d   Raman, Steven ^e   Gee, Michael ^c   Choi, Haesun ^f   Landrum, Lisa ^g   Mannel, Robert ^g   Chuang, Linus ^h   McCourt, Carolyn Kay ^j   Gold, Michael ^k  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b BROWN UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Royal Marsden Hospital   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF OKLAHOMA   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ Michael)   (United States)

^j Woman and Infants Hospital of Rhode Island   (United States)

^k VANDERBILT UNIVERSITY   (United States)

more..

Author keywords

Cervical cancer; Ferumoxtran 10; Lymph node metastasis; MRI; USPIO

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 84923855311     PISSN: None     EISSN: 23520477     Source Type: Journal    
DOI: 10.1016/j.ejro.2014.11.002     Document Type: Article

References (27)

1. Green J., Kirwan J., Tierney J., Vale C., Symonds P., Fresco L., et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005, 3:CD002225.
2. Lukka H., Hirte H., Fyles A., Thomas G., Elit L., Johnston M., et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancerda metaanalysis. Clin Oncol R Coll Radiol 2002, 14:203-212.
3. Perez C.A., Fox S., Lockett M.A., Grigsby P.W., Camel H.M., Galakatos A., et al. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods. Int J Radiat Oncol Biol Phys 1991, 21:885-898.
4. Lanciano R.M., Won M., Coia L.R., Hanks G.E. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 1991, 20:667-676.
5. Horiot J.C., Pigneux J., Pourquier H., Schraub S., Achille E., Keiling R., et al. Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys 1988, 14:605-611.
6. Stehman F.B., Bundy B.N., DiSaia P.J., Keys H.M., Larson J.E., Fowler W.C. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991, 67:2776-2785.
7. Morrow C.P.C.J., Townsend D.E. Synopsis of gynecologic oncology 1993, Churchill Livingstone, New York.
8. Ballon S.C., Berman M.L., Lagasse L.D., Petrilli E.S., Castaldo T.W. Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet Gynecol 1981, 57:90-95.
9. Averette H.E., Dudan R.C., Ford J.H. Exploratory celiotomy for surgical staging of cervical cancer. Am J Obstet Gynecol 1972, 113:1090-1096.
10. Scheidler J., Hricak H., Yu K.K., Subak L., Segal M.R. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. J Am Med Assoc 1997, 278:1096-1101.
11. Michel S.C., Keller T.M., Frohlich J.M., Fink D., Caduff R., Seifert B., et al. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 2002, 225:527-536.
12. Pannu H.K., Wang K.P., Borman T.L., Bluemke D.A. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent. J Magn Reson Imag 2000, 12:899-904.
13. Sigal R., Vogl T., Casselman J., Moulin G., Veillon F., Hermans R., et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial. Eur Radiol 2002, 12:1104-1113.
14. Mack M.G., Balzer J.O., Straub R., Eichler K., Vogl T.J. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 2002, 222:239-244.
15. Harisinghani M.G., Saini S., Weissleder R., Hahn P.F., Yantiss R.K., Tempany C., et al. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol 1999, 172:1347-1351.
16. Triantafyllou M., Studer U.E., Birkhäuser F.D., Fleischmann A., Bains L.J., Petralia G., et al. Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer 2013, 49:616-624.
17. Rockall A.G., Sohaib S.A., Harisinghani M.G., Babar S.A., Singh N., Jeyarajah A.R., et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005, 23:2813-2821.
18. Harisinghani M.G., Saksena M.A., Hahn P.F., King B., Kim J., Torabi M.T., et al. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization. AJR Am J Roentgenol 2006, 186:144-148.
19. Fleiss D.J. Diagnostic tests for gastrocnemius tightness. J Bone Joint Surg Am 2003, 85-A:760. author reply 760.
20. Leisenring W., Alonzo T., Pepe M.S. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics 2000, 56:345-351.
21. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
22. Obuchowski N.A. Hypothesis testing of diagnostic accuracy for multiple readers and multiple tests: An ANOVA approach with dependent observations. Commun Stat Simul 1995, 24:285-308.
23. Hackett T.E., Olt G., Sorosky J.I., Podczaski E., Harrison T.A., Mortel R. Surgical predictors of para-aortic metastases in early-stage cervical carcinoma. Gynecol Oncol 1995, 59:15-19.
24. Inoue T., Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 1990, 65:1923-1927.
25. Wu L., Cao Y., Liao C., Huang J., Gao F. Diagnostic performance of USPIO-enhanced MRI for lymph-node metastases in different body regions: a meta-analysis. Eur J Radiol 2011, 80:582-589.
26. Heesakkers R.A., Jager G.J., Hövels A.M., de Hoop B., van den Bosch H.C., Raat F., et al. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging. Radiology 2009, 251:408-414.
27. Thoeny H.C., Froehlich J.M., Triantafyllou M., Huesler J., Bains L.J., Vermathen P., et al. Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology 2014, (June):132921. [Epub ahead of print].